Exscientia, MD Anderson form AI partnership to develop oncology treatments
The promising candidates emerging from the research collaboration will move on to further development with the therapeutics discovery…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
15 Nov 22
The promising candidates emerging from the research collaboration will move on to further development with the therapeutics discovery…
14 Nov 22
The FDA approval is supported by positive results from the Phase 3 POSEIDON study, which showed a significant…
14 Nov 22
The mRNA manufacturing plant is expected to create regional manufacturing capacities to support BioNTech’s pipeline of mRNA-based vaccines…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
11 Nov 22
VidPrevtyn Beta is a monovalent, recombinant-protein, next-generation Covid-19 vaccine developed by Sanofi, leveraging GSK’s pandemic adjuvant, and is…
11 Nov 22
The authorisation was based on findings of the SAVE-MORE phase 3 study which showed long-term benefits with improved…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
10 Nov 22
To mitigate the current dependency on imported feed, align with self-sufficiency and food security goals in Saudi Arabia, and…
10 Nov 22
The award was presented by 3BL Media's CEO, Dave Armon. "We congratulate the 2022 Responsible CEO Award honorees for…
10 Nov 22
The Underground Donut Tour has been running for 7 years across the US, UK and Ireland, including Chicago,…
10 Nov 22
Cell-based milk is a niche sector that could eat into the $871 billion global dairy sector
10 Nov 22
The British health regulator has expanded the conditional marketing authorisation (CMA) for Novavax’s Nuvaxovid as a booster dose…